Effect of modified diabetic splenocytes on mice injected with splenocytes from multiple low-dose streptozotocin diabetic donors

Experimental Biology and Medicine

Volumn 226, Issue 10, 2001, Pages 898-905

  Arata, Mabel ^a   Bruno, Lidia ^a   Pastorale, Claudia ^a   Pagliero, Fabiola ^a   Basabe, Juan Carlos ^a  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

Diabetes immunomodulation; Diabetic prevention; Insulin secretion patterns; Mononuclear cell transfer; Vaccination

Indexed keywords

MITOMYCIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE TOLERANCE; INSULIN RELEASE; LYMPH NODE; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS; SPLEEN CELL; STREPTOZOCIN DIABETES; T LYMPHOCYTE;

ANIMALIA; MUS MUSCULUS;

EID: 0035525633     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020122601004     Document Type: Article

References (32)

1. Thai A, Eisernbarth G. Natural history of IDDM. Diabetes Rev 1:1-4, 1993.
2. Durinovic-Bello I, Hummel M, Ziegler A. Cellular immune response to diverse islet cell antigen in IDDM. Diabetes 45:795-800, 1996.
3. Haskins K, Wegmann D. Diabetogenic T cell clones. Diabetes 45:1299-1305, 1996.
4. Roep B, Kallan A, Duinkerken G, Arden S, Hutton J, Bruining G, de Vries R. T cell reactivity to β-cell membrane antigens associated with β-cell destruction in IDDM. Diabetes 44:278-283, 1995.
5. Bach JF. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocrine Rev 15:516-542, 1994.
6. Pozzilli P. Prevention of insulin-dependent diabetes mellitus. Diabetes Metab Rev 14:69-84, 1998.
7. Rabinovitch A. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Rev 14:129-151, 1998.
8. Reich EP, Janeway C, Visintin I, Shervin R. Role of T-lymphocytes in murine IDDM. Diabetes Rev 1:174-190, 1993.
9. Lohse A, Mor F, Karin N, Cohen J. Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells. Science 244:820-822, 1989.
10. Gearon C, Hussain M, Vergani D, Peakman M. Lymphocyte vaccination protects prediabetic nonobese diabetic mice from developing diabetes mellitus. Diabetologia 40:1388-1395, 1997.
11. + cells correlate with cytokine profiles in the spontaneously autoimmune diabetic mouse. Diabetes 45:71-78, 1996.
12. Akerblom H, Knip M. Prevention of IDDM: Strategies based on new observations of molecular pathogenesis. Diabetologia 40:743-748, 1997.
13. Reich EP, Scaringe D, Yagi J, Sherwin R, Janeway CH. Prevention of diabetes in NOD mice by injection of autoreactive T-lymphocytes. Diabetes 38:1647-1651, 1989.
14. Enghofer M, Bojunga J, Ludwing R, Oldenburg A, Bernd A, Usadel K, Kusterer K. Lymphocyte transfer in streptozotocin-induced diabetes: Adhesion of donor cells to islet endothelium. Am J Physiol 274:E928-E935, 1998.
15. Kiesel U, Freytag G, Biener J, Kolb H. Transfer of experimental autoimmune insulitis by spleen cells in mice. Diabetologia 19:516-520, 1980.
16. Hafler D, Cohen I, Benjamin D, Weiner H. T cell vaccination in multiple sclerosis: A preliminary report. Clin Immunol Immunopathol 62:307-311, 1992.
17. Van-Laar J, Miltenbur A, Verdong M. Effect of inoculation with attenuates autologous T cell in patients with rheumatoid arthritis. J Autoimmunol 6:159-167, 1993.
18. Kolb H, Krönke KD. IDDM, lessons from the low-dose streptozotocin model in mice. Diabetes Rev 1:116-126, 1993.
19. Arata M, Fabiano de Bruno L, Volpini W, Quintans C, D'Alessandro V, Braun M, Basabe JC. β-Cell function in mice injected with mono-nuclear splenocytes from multiple-dose-streptozotocin diabetic mice. Proc Soc Exp Biol Med 206:76-82, 1994.
20. Arata M, Fabiano de Bruno L, Volpini W, Gagliardi G, Quintans C, Basabe JC. Insulin secretion by pancreas of athymic mice injected with peripheral mononuclear cells from insulin-dependent diabetic patients. Metabolism 44:1435-1441, 1995.
21. Buschard K, Rygaard J. Passive transfer of streptozotocin-induced diabetes mellitus with spleen cells. Acta Pathol Microbiol Scand 85:469-472, 1977.
22. Phillips HJ. Dye exclusion test for cell viability. In: Kruse G, Petterson C, Eds. Tissue: Methods and Applications. New York: Academic Press, pp406-408, 1973.
23. Johnson P, Mardiney M. Binding studies concerning the interaction of radiolabeled sodium chromate with EL4 leukemia. Transplantation 14:253-256, 1972.
24. Braun M, Arata M, D'Alessandro V, López O, Borca M, Basabe JC. Lodging in the pancreas of lymphocytes from normal and diabetic mice. Sixth International Congress of Immunology, Toronto, Canada, #1 (Abstract No. 9), p4b, 1986.
25. Burr IA, Stauffacher W, Balant L, Renold A. E, Grodsky GM. Regulation of insulin release in perifused pancreatic tissue. Acta Diabet Lat 6(Suppl 1):580-586, 1969.
26. Herbert V, Lau K, Gottlieb CW, Bleicher SJ. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375-1384, 1965.
27. Rattcliffe JT. Elements of Mathematical Statistics. London: Oxford University Press, pp120-132, 1969.
28. + T cell subset that inhibits this autoimmune potential. J Exp Med 117:627-636, 1993.
29. Petersen P, van der Keur M, de Vries R, Roep B. Autoreactive and immunoregulatory T cell subset in insulin-dependent diabetes mellitus. Diabetologia 42:443-449, 1999.
30. Yamaoka T, Yano M, Idehara C, Yamada T, Tomonari S, Moritani M, Ii S, Yoshimoto K, Hata J, Itakura M. Apoptosis and remodeling of β-cells by paracrine interferon-γ without insulitis in transgenic mice. Diabetologia 42:566-577, 1999.
31. + cell responses: The alternative approaches. Annu Rev Immunol 15:297-322, 1997.
32. Shehadeh N, Calcinaro F, Bradley, Bruchlin I, Vardi P, Lafferty K. Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet 343:706-707, 1994.